Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd.

China

Back to Profile

1-2 of 2 for Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd. Sort by
Query
Aggregations
Jurisdiction
        United States 1
        World 1
Date
2023 1
2021 1
IPC Class
A61K 36/756 - Phellodendron, e.g. corktree 2
A61K 36/185 - Magnoliopsida (dicotyledons) 1
A61K 36/288 - Taraxacum (dandelion) 1
A61K 36/355 - Lonicera (honeysuckle) 1
A61K 36/489 - Sophora, e.g. necklacepod or mamani 1
See more
Status
Pending 1
Registered / In Force 1
Found results for  patents

1.

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING EGFR-TKIS RELATED SKIN RASH AND USE THEREOF

      
Application Number 17787337
Status Pending
Filing Date 2020-12-18
First Publication Date 2023-02-23
Owner
  • YANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI PHARMACEUTICAL CO., LTD. (China)
  • YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. (China)
  • YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU LONGFENGTANG TRADITIONAL CHINESE MEDICINE CO., LTD. (China)
Inventor Lin, Lizhu

Abstract

A traditional Chinese medicine composition for treating EGFR-TKIs related skin rash and a use thereof, characterized by comprising a therapeutically effective amount of the following components: honeysuckle, dandelion, radix sophorae flavescentis, Kochia scoparia, Dictamnus dasycarpus, tree peony root barks, Cortex Phellodendri, and peppermint. The traditional Chinese medicine composition for treating EGFR-TKIs related skin rash has a certain effect for the treatments of EGFR-TKIs related skin rash and paronychia. The raw materials coordinate with each other, thus can play medicinal effects to a maximum extent, thus significantly improving life quality of patients and prolonging survival period of patients. In addition, the traditional Chinese medicine composition also has advantages of non-toxic side effects and lower treatment cost.

IPC Classes  ?

2.

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING EGFR-TKIS RELATED SKIN RASH AND USE THEREOF

      
Application Number CN2020137615
Publication Number 2021/121388
Status In Force
Filing Date 2020-12-18
Publication Date 2021-06-24
Owner YANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI PHARMACEUTICAL CO., LTD. (China)
Inventor Lin, Lizhu

Abstract

A traditional Chinese medicine composition for treating EGFR-TKIs related skin rash, characterized by comprising a therapeutically effective amount of the following components: honeysuckle, dandelion, radix sophorae flavescentis, Kochia scoparia, Dictamnus dasycarpus, tree peony root barks, Cortex Phellodendri, and peppermint. The traditional Chinese medicine composition for treating EGFR-TKIs related skin rash has a certain effect for the treatments of EGFR-TKIs related skin rash and paronychia. The raw materials coordinate with each other, thus can play medicinal effects to a maximum extent, thus significantly improving life quality of patients and prolonging survival period of patients. In addition, the traditional Chinese medicine composition also has advantages of non-toxic side effects and lower treatment cost.

IPC Classes  ?